Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Feb:210:1-3.
doi: 10.1016/j.thromres.2021.12.012. Epub 2021 Dec 20.

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?

Nathan D Nielsen  1 , Marian A Rollins-Raval  2 , Jay S Raval  2 , Jecko Thachil  3
Affiliations
Comment

Is it hyperfibrinolysis or fibrinolytic shutdown in severe COVID-19?

Nathan D Nielsen et al. Thromb Res. 2022 Feb.
No abstract available

Keywords: COVID-19; D-dimer; Fibrinolysis; Fibrinolytic shutdown; Hyperfibrinolysis; Viscoelastic testing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Comment in

Comment on

  • Impaired fibrinolysis in critically ill COVID-19 patients.
    Bachler M, Bösch J, Stürzel DP, Hell T, Giebl A, Ströhle M, Klein SJ, Schäfer V, Lehner GF, Joannidis M, Thomé C, Fries D. Bachler M, et al. Br J Anaesth. 2021 Mar;126(3):590-598. doi: 10.1016/j.bja.2020.12.010. Epub 2020 Dec 9. Br J Anaesth. 2021. PMID: 33422287 Free PMC article.

References

    1. Thachil J., Juffermans N.P., Ranucci M., Connors J.M., Warkentin T.E., Ortel T.L., Levi M., Iba T., Levy J.H. ISTH DIC subcommittee communication on anticoagulation in COVID-19. J. Thromb. Haemost. 2020 Sep;18(9):2138–2144. doi: 10.1111/jth.15004. - DOI - PMC - PubMed
    1. Wright F.L., Vogler T.O., Moore E.E., Moore H.B., Wohlauer M.V., Urban S., Nydam T.L., Moore P.K., McIntyre R.C., Jr. Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection. J. Am. Coll. Surg. 2020 Aug;231(2):193–203.e1. doi: 10.1016/j.jamcollsurg.2020.05.007. - DOI - PMC - PubMed
    1. Ibañez C., Perdomo J., Calvo A., Ferrando C., Reverter J.C., Tassies D., Blasi A. High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? J. Thromb. Thrombolysis. 2021 Feb;51(2):308–312. doi: 10.1007/s11239-020-02226-0. - DOI - PMC - PubMed
    1. Weiss E., Roux O., Moyer J.-D., Paugam-Burtz C., Boudaoud L., Aizenberg N., Faille D., de Roucort E. Fibrinolysis resistance: a potential mechanism underlying COVID-19 coagulopathy. Thromb. Haemost. 2020;120(09):1343–1345. doi: 10.1055/s-0040-1713637. - DOI - PubMed
    1. Bachler M., Bösch J., Stürzel D.P., Hell T., Giebl A., Ströhle M., Klein S.J., Schäfer V., Lehner G.F., Joannidis M., Thomé C., Fries D. Impaired fibrinolysis in critically ill COVID-19 patients. Br. J. Anaesth. 2021;126(3):590–598. doi: 10.1016/j.bja/2020.12.010. - DOI - PMC - PubMed